Page last updated: 2024-09-02

fingolimod hydrochloride and Fatigue

fingolimod hydrochloride has been researched along with Fatigue in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Al-Iedani, O; Lea, R; Lechner-Scott, J; Ramadan, S; Ribbons, K1
Bryll, A; Drabik, L; Karcz, P; Kolasinska, J; Kolasinska, M; Marona, M; Popiela, T; Skladzien, J; Slowik, A; Szaleniec, J; Wnuk, M; Ziekiewicz, M1
Debs, R; Delvaux, V; Lubetzki, C; Maillart, E; Masingue, M; Papeix, C; Vidal, JS1
Appel, S; Atassi, N; Berry, JD; Gill, A; Goyal, N; Grasso, DL; Macklin, EA; Mateen, F; Mejia, NI; Paganoni, S; Perrin, S; Rivner, M; Simpson, E; Tassinari, V; Vieira, F1

Trials

1 trial(s) available for fingolimod hydrochloride and Fatigue

ArticleYear
Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability.
    Muscle & nerve, 2017, Volume: 56, Issue:6

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Bradycardia; Fatigue; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Single-Blind Method

2017

Other Studies

3 other study(ies) available for fingolimod hydrochloride and Fatigue

ArticleYear
Neurometabolic changes in multiple sclerosis: Fingolimod versus beta interferon or glatiramer acetate therapy.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2022, Volume: 32, Issue:6

    Topics: Fatigue; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting

2022
Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies.
    Ear, nose, & throat journal, 2022, Volume: 101, Issue:10

    Topics: Anosmia; Dimethyl Fumarate; Fatigue; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Recurrence

2022
Fatigue evaluation in fingolimod treated patients: An observational study.
    Multiple sclerosis and related disorders, 2017, Volume: 14

    Topics: Adult; Fatigue; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Treatment Outcome; Young Adult

2017
chemdatabank.com